somatotroph is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Last reviewed on 2025-09-28. Where a claim depends on a specific study, the study is described rather than over-claimed.
CJC-1295 belongs to a family of synthetic peptides modeled on growth hormone-releasing hormone, the hypothalamic signal that prompts the pituitary to release growth hormone. The compound is built from the first twenty-nine amino acids of the natural human sequence, a fragment that retains full receptor binding capacity. Native growth hormone-releasing hormone is degraded quickly in circulation, so the fragment alone has limited practical value. Early work therefore focused on chemical modifications that preserve receptor binding while slowing enzymatic breakdown. The result is a molecule described in the literature as a long-acting analog of the natural hormone.
Two forms circulate under the CJC-1295 name, and they differ by a single appended group. The version without a drug affinity complex carries four substitutions along the peptide chain, including a D-alanine near the amino terminus and replacements at three other positions. These changes block the enzyme dipeptidyl peptidase IV and remove a methionine residue that is prone to oxidation. The modified fragment is frequently labeled MOD GRF 1-29. Naming conventions are inconsistent across informal sources, which is a common source of confusion.
Pharmacokinetic behaviour differs sharply between the two forms. The DAC-bearing peptide shows an extended circulation time measured in days, whereas the version without the complex is cleared within roughly half an hour. This gap shapes how researchers design dosing schedules in animal models. Whether the prolonged presence of the DAC form produces effects meaningfully different from the short-acting variant remains an open question, since comparative human data are scarce.
CJC-1295 is a synthetic peptide designed to mimic growth hormone-releasing hormone (GHRH), the endogenous signal that prompts the pituitary gland to release growth hormone. The compound is a modified fragment of the natural hormone, spanning the first twenty-nine amino acids of GHRH with several substitutions that slow enzymatic breakdown. Two variants circulate in research settings: one carrying a drug affinity complex (DAC) and one without it. The DAC-free form is frequently labelled Mod GRF(1-29) in catalogs and discussion forums.
The peptide binds GHRH receptors on somatotroph cells within the anterior pituitary, triggering a signalling cascade that increases growth hormone secretion. Its improved resistance to dipeptidyl peptidase IV degradation distinguishes it from the parent hormone. In the DAC-bearing version, a maleimide group reacts with a cysteine residue on serum albumin, forming a covalent bond that keeps the peptide in circulation far longer. That albumin attachment is the central design feature separating the two research variants.
| Property | Value | Notes |
|---|---|---|
| Molecular weight (with DAC) | ~3647 Da | Calculated from the full amino acid sequence |
| Molecular weight (without DAC) | ~3368 Da | Mod GRF(1-29) variant |
| Appearance | White lyophilized powder | Typical form supplied for research |
| Solubility | Soluble in water | Dissolves in aqueous buffers |
| Receptor target | GHRH receptor | Expressed on pituitary somatotroph cells |
The albumin-binding version stays in circulation for days, because covalent attachment to serum albumin shields the peptide from rapid filtration and degradation. Reported half-lives for this form fall in the range of several days. The version without the linker is cleared in minutes, with estimates often near thirty minutes in animal work. These figures come from small studies and vary with assay method, species, and route, so they are best read as approximate rather than fixed constants.
Studies in this area generally track growth hormone pulses, insulin-like growth factor 1 concentrations, and occasionally body composition endpoints. Most published human data come from early, small trials, and questions about long-term effects remain open. Whether repeated exposure alters pituitary responsiveness over time is not settled. Analytical work relies on immunoassays for the hormones and on mass spectrometry for the peptide itself, because the two measurements answer different questions.
Characterization of this peptide relies on a small set of routine techniques. Reversed-phase high-performance liquid chromatography separates the target from truncated or oxidized by-products and yields a purity estimate when paired with ultraviolet detection near 214 nanometers. Mass spectrometry, either electrospray coupled to liquid chromatography or matrix-assisted laser desorption, confirms that the observed mass matches the value calculated for the expected sequence. Amino acid analysis, and enzymatic digestion followed by fragment mapping, are used when the sequence itself rather than the mass requires verification.
Stability depends heavily on physical state. A lyophilized powder kept dry, desiccated, and shielded from light typically holds its integrity for months to years at minus twenty degrees Celsius, and longer at minus eighty. Once dissolved, the peptide becomes far more vulnerable, since peptide bond hydrolysis, oxidation of susceptible residues, and aggregation all proceed faster in solution. Buffers near neutral pH are generally gentler than strongly acidic or alkaline conditions. Repeated freeze-thaw cycles and exposure to air-liquid interfaces during vigorous mixing cause losses that are easy to overlook.
=== Climate === The climate of Jammu and Kashmir varies with altitude and across regions. Southern and southwestern areas have a sub-tropical climate, with hot summers and cool winters. This region receives most of its rainfall during the monsoon season. In the east and north, summers are usually pleasant. The effect of the monsoon diminishes in areas lying to the leeward side of the Pir Panjal, such as the Kashmir valley, and much of the rainfall happens in the spring season due to western disturbances. Winters are cold, with temperatures reaching sub-zero levels. Snowfall is common in the valley and the mountain areas.
== Lifecycle == Bowfin spawn in the spring or early summer, typically between April and June, more commonly at night in abundantly vegetated, clear, shallow water in weed beds over sand bars and also under stumps, logs, and bushes. Optimum temperatures for nesting and spawning range between 16 and 19 °C (61 and 66 °F). The males construct circular nests in fibrous root mats, clearing away leaves and stems. Depending on the density of surrounding vegetation, a tunnel-like entrance may be at one side. The diameter of the nests commonly range between 39 and 91 cm (15 and 36 in), at a water depth of 61–92 cm (24–36 in). During spawning season, the fins and underside of male bowfin often change in color to a bright lime green. The courtship/spawning sequence lasts 1-3 hours and can repeat up to five times. Courtship begins when a female approaches the nest. The ritual consists of intermittent nose bites, nudges, and chasing behavior by the male until the female becomes receptive, when the pair lie side by side in the nest. She deposits her eggs, while he shakes his fins in a vibratory movement, and releases his milt for fertilization to occur. A male often has eggs from more than one female in his nest, and a single female often spawns in several nests. Females vacate the nest after spawning, leaving the male behind to protect the eggs during the 8-10 days of incubation. A nest may contain 2,000 to 5,000 eggs, possibly more. Fecundity is usually related to size of the fish, so the roe of a large gravid female may contain over 55,000 eggs.
APCs undergo a process of maturation while migrating, via chemotactic signals, to lymphoid tissues, in which they lose the phagocytic capacity and develop an increased ability to communicate with T-cells by antigen-presentation. As well as in CD8+ cytotoxic T cells, APCs need pMHC-II and additional costimulatory signals to fully activate naive T helper cells.
== Medical uses == Uses include angiography (imaging of blood vessels, including those of the brain and heart), arthrography (imaging of joints), urography (imaging of the urinary system), hysterosalpingography (imaging of the uterus and fallopian tubes), imaging of the gastrointestinal tract, and endoscopic retrograde cholangiopancreatography (ERCP; imaging of the biliary and pancreatic ducts).
=== Pharmacokinetics === The bioavailability of bremelanotide with subcutaneous injection is about 100%. Following a subcutaneous injection of bremelanotide, maximal levels occur after about one hour, with a range of 0.5 to 1.0 hours. The plasma protein binding of bremelanotide is 21%. Bremelanotide is metabolized via hydrolysis of its peptide bonds. The elimination half-life of bremelanotide is 2.7 hours, with a range of 1.9 to 4.0 hours. Bremelanotide is excreted 64.8% in urine and 22.8% in feces.
Sources: en.wikipedia.org
Most Moluccans in northern Maluku (present-day province of North Maluku) are Muslim. Central and southern Maluku (present-day province of Maluku) have approximately equal numbers of Muslims and Christians. There is significant number of native Hindus (Tanimbar Kei people) living in the Kei Islands, which is a predominantly Catholic region. This is because, according to oral traditions, their ancestors came from Bal (Bali) during the Majapahit era. Additionally, they practice local customary law called Larvul Ngabal (transl. "red blood and spear from Bali"). The most common religion amongst Moluccans in the Netherlands is Protestantism, followed by Islam.
In 2006 and 2007, a series of studies provided arguably the first documented examples of de novo gene birth that did not involve overprinting. These studies were conducted using the accessory gland transcriptomes of Drosophila yakuba and Drosophila erecta and they identified 20 putative lineage-restricted genes that appeared unlikely to have resulted from gene duplication. Levine and colleagues identified and confirmed five de novo candidate genes specific to Drosophila melanogaster and/or the closely related Drosophila simulans through a rigorous approach that combined bioinformatic and experimental techniques. Since these initial studies, many groups have identified specific cases of de novo gene birth events in diverse organisms. The first de novo gene identified in yeast, BSC4 gene was identified in S. cerevisiae in 2008. This gene shows evidence of purifying selection, is expressed at both the mRNA and protein levels, and when deleted is synthetically lethal with two other yeast genes, all of which indicate a functional role for the BSC4 gene product. Historically, one argument against the notion of widespread de novo gene birth is the evolved complexity of protein folding. Interestingly, Bsc4 was later shown to adopt a partially folded state that combines properties of native and non-native protein folding. In plants, the first de novo gene to be functionally characterized was QQS, an Arabidopsis thaliana gene identified in 2009 that regulates carbon and nitrogen metabolism.
Bitcoin (abbreviation: BTC; sign: ₿) is the first decentralized cryptocurrency. Based on a free-market ideology, bitcoin was invented in 2008 when an unknown person published a white paper under the pseudonym of Satoshi Nakamoto. Use of bitcoin as a currency began in 2009, with the release of its open-source implementation. From 2021 to 2025, El Salvador adopted it as legal tender currency before revoking it. As bitcoin is pseudonymous, its use by criminals has attracted the attention of regulators, leading to its ban by several countries. Bitcoin works through the collaboration of computers, each of which acts as a node in the peer-to-peer bitcoin network. Each node maintains an independent copy of a public distributed ledger of transactions, called a blockchain, without central oversight. Transactions are validated through the use of cryptography, preventing one person from spending another person's bitcoin, as long as the owner of the bitcoin keeps certain sensitive data secret. Consensus between nodes about the content of the blockchain is achieved using a computationally intensive process based on proof of work, called mining, which is performed by purpose-built computers. Mining consumes large quantities of electricity, with surveyed miners reporting that 52% of their electricity use came from sustainable energy sources, and has been criticized for its environmental impact.
For services to Urban Regeneration. William James Ferguson, , lately Vice Chairman, Scottish Agricultural College. For services to Agriculture and to Education. Thelma Fisher, Director, National Family Mediation. For services to the community. David Fleming. For services to Museums. Douglas Munro Fleming, General Medical Practitioner, Birmingham. For services to Medicine. George Malcolm Fordy, Chairman and Chief Executive, FT Construction Group. For services to the Building Industry. Michael Hartley Foulds, Member, Association of Chartered Certified Accountants. For services to Accountancy. Major Roy Sutherland Fox. For services to the Soldiers', Sailors' and Airmen's Families Association in Suffolk. Stephen Giles Frankiss, Grade 6, Department of Transport. Jacqueline Dorothy Fuller, Officer in Charge, Board of Inland Revenue. Robert Alan Gailey. For services to Museums and Galleries. William Alistair Galston, lately Chief Inspector, Gaming Board of Great Britain. John Frederick Gibson, Secretary Scientific, Royal Society of Chemistry. For services to Chemistry. Thelma Joyce Gillen, Grade 7, Ministry of Defence. Michael John Goodman, Senior Group Leader, Pulse Power Research, AWE Aldermaston. For services to the Defence Industry. Gerard Graham. For services to the community in Tyne and Wear. William Grant, . For services to Environmental Protection and to the Arts. Frederick Howard Green, Education Adviser, National Association of Independent and non-Maintained Schools. For services to Special Needs Education.
Sources: en.wikipedia.org
The synthetic peptide keeps the receptor-binding region of GHRH but carries substitutions that resist enzymatic cleavage. In the DAC version, an added group also anchors the molecule to albumin, extending its presence in the bloodstream.
The maleimide group forms a covalent link with albumin, an abundant blood protein. This attachment slows clearance, so a single administration persists much longer than the unmodified peptide. The feature is the main reason the two variants are handled differently in study design.
It is not an approved therapeutic product in major regulatory jurisdictions. It appears in research chemical catalogs and scientific literature rather than pharmacy shelves. Clinical development was limited and did not reach approval.
Reported values cluster in the range of several days, reflecting slow release from the albumin complex. Estimates differ across species and assay platforms. The figure describes circulation time in study settings rather than a fixed property.